8-K - BriaCell Therapeutics Corp. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

BriaCell Therapeutics Corp. announced on February 18, 2026, that it entered into an asset purchase agreement. The press release dated February 18, 2026, is attached as Exhibit 99.1 to the 8-K filing dated February 20, 2026.

Key Takeaways

1Entered into asset purchase agreement on February 18, 2026

2Press release issued February 18, 2026 as Exhibit 99.1

3Filed under Item 8.01 Other Events

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events On February 18, 2026, BriaCell Therapeutics Corp. (the “Company”) announced that it has entered into an asset purchase agreement (the “Purchase A

Other Event

$3.0M

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated February 18, 2026 104 Cover Page Interactive Data File (embedde

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1